When was Sensate founded?

Sensate was founded in 2019 and raised its 1st funding round within a year of its incorporation.

Where is Sensate located?

Sensate is headquartered in Los Angeles, United States.

Who is the current CEO of Sensate?

Anna Gudmundson of Sensate. They have also founded 1 company and are an angel investors in 1 startup.

Which legal entities is Sensate associated with?

Sensate is associated with Bioself Technology Ltd and 2 others.

How many employees does Sensate have?

As of Aug 11, 2025, the latest employee count at Sensate is 4.

Is Sensate a funded company?

Sensate is a funded company, having raised a total of $6.15M across 4 funding rounds to date. The company's 1st funding round was a $***** Seed round, raised on Dec 19, 2019.

How much is Sensate worth?

The latest valuation of Sensate is $***** as of Aug 11, 2025.

When was the latest funding round of Sensate?

Sensate's latest funding was a $***** Seed round on Dec 09, 2024, with participation from 0 investor.

What is the annual revenue of Sensate?

Annual revenue of Sensate is between $1M and $10M as on Dec 31, 2023

Where does Sensate rank among its competitors?

Sensate ranks 27th amongst 228 active competitors, of which 64 are funded. It stands 8th in terms of total funding among its competitors. The most recent competitor to raise funding was BrainCo, which secured an undisclosed amount in Sep, 2026.

Who are the top competitors of Sensate?

Sensate's top competitors include Muse, Flow Neuroscience and Apollo Neuroscience. Among them, BrainCo secured the most recent funding round in September, 2026.

Sensate - 2026 Company Profile, Team, Funding & Competitors

Sensate is a seed company based in Los Angeles (United States), founded in 2019 by Anna Gudmundson. It operates as a Developer of a relaxation device for stress and anxiety management. Sensate has raised $6.15M in funding from Incisive Ventures, with a current valuation of $*****. The company has 228 active competitors, including 64 funded and 6 that have exited. Its top competitors include companies like Muse, Flow Neuroscience and Apollo Neuroscience.

Company Details

Developer of a relaxation device for stress and anxiety management. It provides infrasonic resonance technology-based device and application that helps to improve stress levels, sleep, and concentration. It also assists with heart rate variability and helps in non-invasive vagus nerve stimulation.

Website: www.getsensate.com/
Social
Email ID: *****@getsensate.com

Key Metrics

Founded Year

2019

Location

Los Angeles, United States

Stage

Seed

Total Funding

$6.15M in 4 rounds

Latest Funding Round

Seed, Dec 09, 2024, $*****

Post Money Valuation

$***** as on Aug 11, 2025

Investors

Incisive Ventures & 38 more

Ranked

27^th among 228 active competitors

Annual Revenue

$1M - $10M as on Dec 31, 2023

Employee Count

4 as on Aug 11, 2025

Similar Companies

Muse & 225 more

View Sensate's full profile

Sensate is associated with 3 legal entities given below:

Legal Entity Name	Date of Incorporation	Revenue	Latest Employee Count	Documents
BIOSELF TECHNOLOGY LTD CIN: 9818825 , United Kingdom, Active	Oct 12, 2015	-	3 (As on Dec 31, 2022)
Sensate Inc. CIN: 0001917559 , United States, Active	Nov 12, 2021	$1M - $10M (As on Dec 31, 2023)	4 (As on Aug 11, 2025)	-
Bioself Technology Ltd CIN: 9818825 , Germany, Active	Oct 11, 2015	-	3 (As on Oct 31, 2022)

Sensate has raised a total funding of $6.15M over 4 rounds. Its first funding round was on Dec 19, 2019. Sensate has 14 institutional investors and 25 angel investors.

Here is the list of recent funding rounds of Sensate:

Filter this list

Date of Funding	Funding Amount	Round Name	Post-Money Valuation	Revenue Multiple	Lead Investors	Other Investors
Dec 09, 2024	3053897	Seed	9174478	1451223	5787205	1419479
Mar 16, 2023	7046296	Seed	4362474	1935281	2403049	Share Ventures & 5 more
Sep 07, 2022	7967693	Seed	9515180	9611778	2641747	3864143

Access funding benchmarks and valuations. Sign up today!

View details of Sensate's funding rounds and investors

The founders of Sensate is Anna Gudmundson. Anna Gudmundson is the CEO of Sensate.

Here are the details of Sensate's key team members:

Anna Gudmundson: Co-Founder & CEO of Sensate. They are also an angel investor in 1 startup and serve on the board of 1 company.
Contact Info: 1 email address

Sensate's Board of Directors

Sensate's board has 2 active members. Anna Gudmundson and Stefan Chmelik are part of team.

Here is the list of Sensate's board of directors:

Name	Type	Representing	Status	Duration
Anna Gudmundson	Team	-	Current	6y 8m
Stefan Chmelik	Team	-	Current	10y 11m

View details of Sensate's Founder profiles and Board Members

Sensate's employee count trend

Sensate has 4 employees as of Aug 25. Here is Sensate's employee count trend over the years:

Uncover Sensate's growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of Sensate include Muse, Flow Neuroscience and Apollo Neuroscience. Here is the list of Top 10 competitors of Sensate, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	Muse 2007, Toronto (Canada), Series C	Provider of brainwave tracking devices and related premium subscription services	$57.4M	OMERS, Export Development Canada & 22 others	63/100
2nd	Flow Neuroscience 2016, Malmo (Sweden), Series A	Provider of a wearable device for stress and anxiety management	$11.9M	Khosla Ventures, HAX & 6 others	61/100
3rd	Apollo Neuroscience 2017, Pittsburgh (United States), Series A	Developer of wearable technology for stress reduction, sleep improvement, and performance enhancement	$30.7M	Noetic Psychedelic Fund, Republic Capital ... & 9 others	61/100
4th	Freespira 2008, Danville (United States), Series D	Medical device & Mobile app to treat panic disorders	$48.9M	Lightspeed Venture Partners, Aphelion Capital ... & 4 others	60/100
5th	BrainCo 2015, Somerville (United States), Series B	Provider of a prosthetic hand and EEG headband for brain signal	$292M	Walden International, IDG Capital & 10 others	58/100
6th	Mave Health 2023, Bengaluru (India), Seed	Provider of NIBS wearable device designed to improve brain health	$2.85M	Blume Venture, iSeed & 34 others	58/100
7th	NeuroSigma 2008, Los Angeles (United States), Seed	Develops and commercializes trigeminal nerve stimulation (TNS) devices for treatment of psychiatric disorders	$2.92M	Checkmate Capital, NINDS & 2 others	57/100
8th	Neurolief 2012, Herzliya (Israel), Series A	Wearable device for neurological and neuropsychiatric disorders	$11M	Champel Capital, Terra Venture Partners & 2 others	54/100
9th	Pulsetto 2021, Vilnius (Lithuania), Seed	Provider of neuromodulation devices for stress and anxiety management	$3.1M	Kilo Health, ScaleWolf	52/100
10th	Feel Therapeutics 2015, San Francisco (United States), Series A	Provider of digital Precision Medicine company leveraging objective data and passive measurement for mental healthcare	$30M	Felicis Ventures, HAX & 20 others	50/100
27th	Sensate 2019, Los Angeles (United States), Seed	Developer of a relaxation device for stress and anxiety management	$6.15M	37 Angels, TenOneTen & 37 others	39/100